Revenue
2010
2011
2012
2013
2014
2015
| 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $2.0M | $1.5M | $1.1M | $980,909 | $824,508 |
| Gross profit | $1.5M | $1.8M | $1.4M | — | — | — |
| Gross margin | 76.75% | 87.94% | 88.32% | — | — | — |
| Research & development | $122,487 | $115,496 | $85,037 | — | — | — |
| Operating expenses | $2.5M | $1.5M | $1.1M | $900,439 | $924,713 | $1.0M |
| Operating income | −$559,187 | $541,236 | $479,848 | $170,431 | $56,196 | −$180,470 |
| Operating margin | −28.89% | 26.56% | 31.01% | 15.92% | 5.73% | −21.89% |
| EBITDA | −$541,897 | $553,180 | $484,888 | $182,516 | $70,059 | −$166,548 |
| EBITDA margin | −28.00% | 27.15% | 31.33% | 17.04% | 7.14% | −20.20% |
| Net income | −$398,221 | $1.0M | $871,248 | $152,373 | $41,676 | −$192,470 |
| Net profit margin | −20.57% | 50.53% | 56.30% | 14.23% | 4.25% | −23.34% |
| Basic EPSper basic share | -$0.10 | $0.40 | $0.40 | $0.10 | — | -$0.10 |
| Diluted EPSper diluted share | -$0.10 | $0.40 | $0.40 | $0.10 | — | -$0.10 |
Reported shareholders